Viewing Study NCT00324051

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:55 PM

Ignite Modification Date: 2025-12-25 @ 9:51 PM

Study NCT ID: NCT00324051

Status: COMPLETED

Last Update Posted: 2019-09-12

First Post: 2006-05-08

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet

Sponsor: Eli Lilly and Company

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module